Daniel Abdun-Nabi - 01 Jun 2021 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
Director
Signature
/s/ Carl A. Valenstein, attorney-in-fact
Issuer symbol
APVO
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
02 Jun 2021, 19:32:14 UTC
Previous filing
07 Mar 2023
Next filing
08 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Stock Option (right to buy) Award $0 +2,678 $0.000000 2,678 01 Jun 2021 Common Stock 2,678 $26.15 Direct F1
transaction APVO Restricted Stock Unit Award $0 +893 $0.000000 893 01 Jun 2021 Common Stock 893 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three approximately equal annual installments beginning on June 1, 2022.
F2 Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis.
F3 The RSUs vest in three approximately equal annual installments beginning on June 1, 2022.